Entellus Medical Gross profit (Q2, 2017)16.3 M

Entellus Medical Gross profit margin (Q2, 2017), %73.6%

Entellus Medical Net income (Q2, 2017)-8 M

Entellus Medical EBIT (Q2, 2017)-7.6 M

Entellus Medical Cash, 30-Jun-201762.9 M

Entellus Medical EV545.2 M

Entellus Medical revenue was $75.18 m in FY, 2016 which is a 22.1% year over year increase from the previous period.

USD | FY, 2015 | FY, 2016 |
---|---|---|

## Revenue | 61.6 m | 75.2 m |

| 22% | |

## Cost of goods sold | 14.1 m | 18.7 m |

## Gross profit | 47.5 m | 56.5 m |

| 77% | 75% |

## R&D expense | 5.4 m | 7.8 m |

## General and administrative expense | 13 m | 18.6 m |

## Operating expense total | 18.4 m | 26.4 m |

## EBIT | (15.9 m) | (26.7 m) |

| (26%) | (36%) |

## Interest expense | 2.6 m | 2.2 m |

## Interest income | 171 k | 278 k |

## Income tax expense | (6 k) | |

## Net Income | (18.3 m) | (28.7 m) |

USD | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|---|

## Revenue | 15.2 m | 14.8 m | 16.9 m | 18.7 m | 17.9 m | 19.1 m | 22.1 m |

## Cost of goods sold | 3.3 m | 3.4 m | 4 m | 4.5 m | 4.6 m | 4.9 m | 5.8 m |

## Gross profit | 11.8 m | 11.4 m | 12.9 m | 14.3 m | 13.2 m | 14.2 m | 16.3 m |

| 78% | 77% | 76% | 76% | 74% | 74% | 74% |

## R&D expense | 1.3 m | 1.4 m | 1.9 m | 1.9 m | 2 m | 2.1 m | 2.1 m |

## General and administrative expense | 3.1 m | 3.2 m | 3.9 m | 3.8 m | 4.8 m | 4.7 m | 5.8 m |

## Operating expense total | 14.2 m | 16.9 m | 19.3 m | 18.8 m | 22.2 m | 22 m | 23.9 m |

## EBIT | (2.4 m) | (5.6 m) | (6.4 m) | (4.5 m) | (9 m) | (7.8 m) | (7.6 m) |

| (15%) | (38%) | (38%) | (24%) | (50%) | (41%) | (35%) |

## Interest expense | 562 k | 561 k | 562 k | 562 k | 562 k | 565 k | 446 k |

## Interest income | 50 k | 47 k | 70 k | 83 k | 75 k | 62 k | 107 k |

## Income tax expense | 34 k | (3 k) | (3 k) | ||||

## Net Income | (2.9 m) | (6.1 m) | (6.9 m) | (5 m) | (9.5 m) | (8.3 m) | (8 m) |

USD | FY, 2015 | FY, 2016 |
---|---|---|

## Cash | 28.5 m | 21.4 m |

## Accounts Receivable | 10.4 m | |

## Inventories | 3.9 m | 7.2 m |

## Current Assets | 83 m | 54.9 m |

## PP&E | 4.1 m | 6.5 m |

## Goodwill | 477 k | |

## Total Assets | 87.4 m | 72.1 m |

## Accounts Payable | 2.2 m | 2.8 m |

## Short-term debt | 9.1 m | |

## Current Liabilities | 9.2 m | 24.9 m |

## Total Debt | 9.1 m | |

## Total Liabilities | 36.6 m | |

## Additional Paid-in Capital | 179.7 m | 186.4 m |

## Retained Earnings | (122.1 m) | (150.8 m) |

## Total Equity | 57.6 m | 35.4 m |

## Debt to Equity Ratio | 0.3 x | |

## Debt to Assets Ratio | 0.1 x | |

## Financial Leverage | 1.5 x | 2 x |

USD | Q2, 2015 | Q3, 2015 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
---|---|---|---|---|---|---|

## Cash | 7.5 m | 8.7 m | 8 m | 15.2 m | 65.2 m | 62.9 m |

## Accounts Receivable | 9.3 m | 10.2 m | ||||

## Inventories | 2.4 m | 3.3 m | 4.7 m | 5.9 m | 7.3 m | 7.7 m |

## Current Assets | 92.8 m | 89.1 m | 64.6 m | 58.3 m | 91.2 m | 88.7 m |

## PP&E | 2.8 m | 3.7 m | 5.2 m | 6.5 m | 6.6 m | 6.7 m |

## Goodwill | 4.2 m | 4.3 m | 477 k | 477 k | ||

## Total Assets | 95.8 m | 92.9 m | 80.5 m | 75.7 m | 108.2 m | 105.6 m |

## Accounts Payable | 2.3 m | 3.4 m | 3.1 m | 4 m | 2.6 m | 3 m |

## Short-term debt | 2.5 m | 4.1 m | 4 m | 6.6 m | 9.1 m | 9.1 m |

## Current Liabilities | 11.1 m | 15 m | 15.4 m | 21 m | 19.9 m | 22.9 m |

## Total Debt | 2.5 m | 4.1 m | 4 m | 6.6 m | 9.1 m | 9.1 m |

## Total Liabilities | 29 m | 31.4 m | 32 m | 35.2 m | 33.2 m | 36.2 m |

## Additional Paid-in Capital | 177.8 m | 178.6 m | 182.5 m | 184.1 m | 234.2 m | 236.6 m |

## Retained Earnings | (111 m) | (117 m) | (134 m) | (143.5 m) | (159.1 m) | (167.2 m) |

## Total Equity | 66.9 m | 61.6 m | 48.5 m | 40.5 m | 74.9 m | 69.3 m |

## Financial Leverage | 1.4 x | 1.5 x | 1.7 x | 1.9 x | 1.4 x | 1.5 x |

USD | FY, 2015 | FY, 2016 |
---|---|---|

## Net Income | (18.3 m) | (28.7 m) |

## Depreciation and Amortization | 1 m | 2.1 m |

## Inventories | (1.5 m) | (3.3 m) |

## Accounts Payable | (206 k) | 596 k |

## Cash From Operating Activities | (14.2 m) | (20.1 m) |

## Purchases of PP&E | (3.4 m) | |

## Cash From Investing Activities | (42.1 m) | 12.3 m |

## Cash From Financing Activities | 81.3 m | 782 k |

## Interest Paid | 1.9 m | 1.9 m |

USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
---|---|---|---|---|---|---|---|

## Net Income | (2.9 m) | (6.1 m) | (6.9 m) | (5 m) | (9.5 m) | (8.3 m) | |

## Accounts Receivable | 8.4 m | 9.3 m | 10.2 m | ||||

## Inventories | 2.6 m | 2.4 m | 3.3 m | 4.7 m | 5.9 m | 7.3 m | |

## Accounts Payable | 2 m | 2.3 m | 3.4 m | 3.1 m | 4 m | 2.6 m |

USD | Y, 2017 |
---|---|

## EV/EBIT | -71.4 x |

## Financial Leverage | 1.5 x |

Report incorrect company information